Search research articles
Contact Us
Filters
Showing results (71-80 of 158) with videos related to
Page
of 16
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 22, 2021
Frailty, lifestyle, genetics and dementia risk
David D Ward, Janice M Ranson, Lindsay M K Wallace, et al.
Cancer
|
February 1, 1993
Antigrowth factor strategies
C Myers, J Trepel, O Sartor, et al.
Neurology. Clinical Practice
|
May 2, 2019
Predictors of dementia misclassification when using brief cognitive assessments
Janice M Ranson, Elżbieta Kuźma, William Hamilton, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 20, 2005
A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer
S Baka, M Ranson, P Lorigan, et al.
Cancer Chemotherapy and Pharmacology
|
December 4, 2009
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin
M Ranson, H Shaw, J Wolf, et al.
British Journal of Cancer
|
January 7, 2012
Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours
E Dean, M R Middleton, T Pwint, et al.
British Journal of Cancer
|
December 6, 2000
Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours
S L Cheeseman, M Brannan, A McGown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Phase II study of oral topotecan in advanced non-small cell lung cancer
S C White, S Cheeseman, N Thatcher, et al.
British Journal of Cancer
|
November 12, 2009
A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC
E J Dean, T Ward, C Pinilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Suramin for breast and prostate cancer: a pilot study of intermittent short infusions without adaptive control
P J Woll, M Ranson, J Margison, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 158) with videos related to
Sort By:
Page
of 16
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 22, 2021
Frailty, lifestyle, genetics and dementia risk
David D Ward, Janice M Ranson, Lindsay M K Wallace, et al.
Cancer
|
February 1, 1993
Antigrowth factor strategies
C Myers, J Trepel, O Sartor, et al.
Neurology. Clinical Practice
|
May 2, 2019
Predictors of dementia misclassification when using brief cognitive assessments
Janice M Ranson, Elżbieta Kuźma, William Hamilton, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 20, 2005
A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer
S Baka, M Ranson, P Lorigan, et al.
Cancer Chemotherapy and Pharmacology
|
December 4, 2009
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin
M Ranson, H Shaw, J Wolf, et al.
British Journal of Cancer
|
January 7, 2012
Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours
E Dean, M R Middleton, T Pwint, et al.
British Journal of Cancer
|
December 6, 2000
Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours
S L Cheeseman, M Brannan, A McGown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Phase II study of oral topotecan in advanced non-small cell lung cancer
S C White, S Cheeseman, N Thatcher, et al.
British Journal of Cancer
|
November 12, 2009
A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC
E J Dean, T Ward, C Pinilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Suramin for breast and prostate cancer: a pilot study of intermittent short infusions without adaptive control
P J Woll, M Ranson, J Margison, et al.
Page
of 16